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Abstract
Background: Immune thrombocytopenia (ITP) is a hematological disorder with an isolated decrease in number
of circulating platelets. Bee venom therapy (BVT) is a form of alternative medicine. It is still being practiced in the
Middle East and other parts of Asia. In BVT, acupuncture points are used to inject diluted bee venom into the body.
The pharmacological basis behind BVT is not fully understood. However, it has been used to treat various medical
conditions such as arthritis and low back pain. On the other hand there have been a number of reported complications
of BVT use such as ITP. We present a case report on ITP after BVT.
Case presentation: A 61 year old lady presented with gum bleeding and ecchymosis and found to have isolated
thrombocytopenia (platelet count of 9 × 109/L) after receiving four direct bee sting sessions. There was no evidence of
any other risk factors of ITP.
Conclusion: Bee venom components and toxicity may be associated with thrombocytopenia as a complication.
Further research is needed to postulate guidelines and protocol for BVT. In the meantime, monitoring of the practice of
BVT should be made, with an emphasis on patient education regarding the safety profile and associated risks compared
to the gained benefits.
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Background
Immune thrombocytopenia (ITP) is a hematological dis-
order in which there is an isolated decrease in number
of circulating platelets [1]. In either primary ITP or
secondary ITP, it is thought to be an immune mediated
process [2, 3]. The disease may manifest from simple
bruising to overt bleeding with an incidence in adults
ranging from approximately 1.6 to 3.9 per 100,000 per-
sons per year with a higher incidence in women than
men [4–6]. Most adult patients presenting with acute
ITP recover within weeks however some may progress
to a chronic form of the disease [3].
Bee Venom therapy (BVT) is a well-known form of
alternative and complementary medicine. There is a
belief that ancient Egypt, Greece and China had applied
BVT for patients suffering from rheumatism [7]. It is still
being practiced in the Middle East as well as other parts
in Asia. BVT is where acupuncture points are used to
inject bee venom into the body either by direct sting or
diluted injection [7].
There is no significant evidence supporting the effect-
iveness of BVT, but several trials have been and are
currently conducted to support the use of BVT. There
have been many reported complications of bee stings
in the literature. These are mainly thought to be induced
by the active components of bee venom. We may
group these complications according to system affection;
hematological, renal, liver, cardiovascular, musculoskeletal,
central nervous system and multi-organ failure [8–16].
The most striking of these are potential anaphylactic
reactions which may be life threatening [7]. These compli-
cations include three case reports of thrombocytopenia. In
this report we describe a case of adult onset ITP following
BVT without evidence of a known secondary cause of
ITP. We aim to raise awareness of a possible complication
of BVT.
Case presentation
A 61 year old lady presented to the emergency depart-
ment with 1 day history of bleeding from her gums. She
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denied any history of hematemesis, hemoptysis or epi-
staxis. Furthermore, she did not have melena or hematuria
with no preceding history of flu-like symptoms. She no-
ticed a non-itchy well demarcated rash, bluish in color on
her right forearm and abdomen (Figs. 1 and 2).
With regards to her previous medical history, she was
diagnosed with lumbar disc prolapse. Recently, she has
started BVT sessions to relieve her pain. She received
four once weekly direct bee sting sessions, first was a
month prior to her presentation. Nevertheless, she is
morbidly obese with a BMI of more than 40 and has
bilateral knee osteoarthritis as a consequence. She did
not use any new herbal or prescribed medications.
Upon arrival to the emergency department, she was fully
oriented. She did not show any sign of hemodynamic
instability. Systemic examination was unremarkable
except for the skin, which showed two ecchymotic
rashes. The first one was inferior to the umbilicus,
round and macular, bluish in color, with a diameter
of 5 cm (Fig. 1). The second was in the planter
aspect of the right forearm distally; with a diameter
of 2 cm (Fig. 2).
Laboratory investigations were as follows: Full blood
count of WBC 5.8 × 109/L, Platelets 9 × 109/L (manual
count: 15 × 109/L), Hb 140 g/L. Her urea and electrolyte;
Urea 3.3 mmol/L, Crea 41 mmol/L, K 3.5 mmol/L, Na
140 mmol/L, Glu 5 mmol/L, HCO3 25 mmol/L. Liver
function test and liver enzymes; Alkaline phosphatase
154 IU/L, ALT 41 IU/L, AST35 IU/L, Bil 11 umol/L,
INR 0.94, APTT 32 s, protein 78 g/L, albumin 35 g/L,
TSH 2 mmol/L. After reviewing her previous blood
work up, she had a platelet count of 240 × 109/L few
weeks before starting her first BVT session.
Her peripheral blood smear showed: WBC; few acti-
vated lymphocyte and neutrophils with left shift, RBC;
normocytic and normochromic, Platelets; giant platelets
seen. Disseminated intravascular coagulation was ruled
out based on laboratory test and blood film. She was
assessed by a consultant hematologist and a diagnosis of
ITP was established. Ultrasound abdomen showed a
complete normal study. HCV, HBV and HIV screening
was negative.
She was admitted to the hospital for 3 days. Initially,
she received a 2 days course of immunoglobulin (IVIG
90 g once daily). After that she received a course of
prednisolone (90 mg once daily for 2 weeks). She was
clinically stable throughout her hospital stay with no
further symptoms. On the day of discharge, her platelet
count was 42 × 109/L. The patient was followed up in
the outpatient clinic after 8 weeks. She was asymptom-
atic and her platelet count was 162 × 109/L.
Conclusions
It is believed that BVT is effective in treating various
conditions including rheumatoid arthritis, bursitis, ten-
donitis, post-herpetic neuralgia, multiple scleroses, gout,
burns and infection [7]. There are a number of studies
addressing the potential effectiveness of BVT in treating
cancer patients [7]. Current research shows a potential
therapeutic use of BVT in treating low back pain.
However, despite the promising nature of the research
the Food and Drug Administration (FDA) has not yet
approved it [7].
ITP may be primary when no cause is identified. It
accounts for approximately 80 % of all ITP cases [17].
Secondary causes include autoimmune causes (SLE,
Antiphospholipid syndrome, Evans syndrome), Infec-
tious (Hepatitis C, HIV, H.pylori), neoplastic (Chronic
lymphocytic leukemia, lymphomas) and other rare
causes [17]. All common secondary causes of ITP were
excluded in our case.
In a review of the literature three case reports of bee
sting induced ITP were identified. The first was reported
by Tanphaichitr in 1982 [18]. The second case was about
a 9 year old female who developed ITP with a platelet
count of 15 × 109/L post accidental bee sting in the
mouth. This second case was reported by Nam dev in
2009 [19]. The third case reported in 2011 by Akbayram,
Fig. 1 Abdominal ecchymosis size (5 cm diameter)
Fig. 2 Right forearm ecchymosis size (2 cm diameter)
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in which a 4 year old boy developed an ITP with a
platelet count of 5 × 109/L after a honeybee bite [20].
The drop in our patient’s platelet count was suggestive
to be due to BVT.
The pharmacological basis behind BVT is not fully
understood. However, there are suggestions that bee
venom has a number of pharmacological actions includ-
ing analgesic, anti-inflammatory, and anti-cancer actions
through multiple mechanisms [7]. The active compo-
nents of bee venom include apamin, phospholipase A2
(PLA2), melitin, mast cell degradation peptide and
histamine [21]. These components have an immuno-
logical effect on the body [22]. A number of studies tried
to explain the pathophysiology behind the complications
associated with use of bee venom therapy. The PLA2 is
known to have a hematological affect including coagula-
tion abnormalities [23]. Yuan et al. reported that PLA2
from bee and wasp venom inhibits platelet aggregation
through the formation of lysophosphatidylcholine [24].
This may help us speculate that bee venom induces a
host of immunological reactions. However, further re-
search is required to clarify these mechanisms.
In conclusion, with the present knowledge of bee
venom components and toxicity it is reasonable to asso-
ciate thrombocytopenia as a complication of BVT how-
ever its use should be further studied to avoid potential
consequences. Further research is needed to postulate
guidelines and protocol for BVT. In the meantime, mon-
itoring of the practice of BVT should be made, with an
emphasis on patient education regarding the safety pro-
file and associated risks compared to the gained benefits.
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